Back
PT Bank Central Asia Tbk Vs. Corcept Therapeutics Industry Stock Comparison
Sell
44
PBCRF
PT Bank Central Asia Tbk
Last Price:
$0.51
Seasonality Move:
3.87%
Buy
52
CORT
Corcept Therapeutics
Last Price:
$70.19
Seasonality Move:
6.42%
Sell
44
PT Bank Central Asia Tbk (PBCRF)
is a Sell
Is PT Bank Central Asia Tbk a Buy, Sell or Hold?
-
The current PT Bank Central Asia Tbk [PBCRF] share price is $0.51. The Score for PBCRF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
PBCRF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $74.65. The Score for CORT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PBCRF Stock Price Chart
What is PT Bank Central Asia Tbk's stock price today?
-
The PT Bank Central Asia Tbk share price today is $0.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBCRF is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $74.65The current trend is moderately bullish and CORT is experiencing slight buying pressure.
PBCRF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 48.33 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.48 - 0.54) | Sell |
| Bollinger Bands (100): | (0.52 - 0.62) | Sell |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 20.64 | Buy |
| Relative Strength Index (14 RSI): | 54.3 | Buy |
| Chaikin Money Flow: | 841196 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.33 - 78.25) | Buy |
| Bollinger Bands (100): | (50.74 - 69.42) | Buy |
PBCRF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.51 | Sell |
| 20-day SMA: | 0.5 | Buy |
| 50-day SMA: | 0.53 | Sell |
| 200-day SMA: | 0.61 | Sell |
| 8-day EMA: | 0.51 | Buy |
| 20-day EMA: | 0.51 | Buy |
| 50-day EMA: | 0.53 | Sell |
| 200-day EMA: | 0.59 | Sell |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 78.72 | Sell |
| 20-day SMA: | 65.73 | Buy |
| 50-day SMA: | 64.92 | Buy |
| 200-day SMA: | 49.1 | Buy |
| 8-day EMA: | 74.01 | Buy |
| 20-day EMA: | 53.91 | Buy |
| 50-day EMA: | 29.29 | Buy |
| 200-day EMA: | 8.68 | Buy |
PT Bank Central Asia Tbk Earnings Growth & PBCRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
PT Bank Central Asia Tbk Technical Analysis
| Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||